Market Overview:
The global carboplatin market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for effective and less toxic anticancer drugs, and growing focus on personalized medicine. The global carboplatin market is segmented by type into carboplatin crystal and carboplatin powder. The injection segment is expected to account for the majority share of the global market in 2018. However, the powder segment is projected to grow at a higher CAGR during the forecast period owing to its advantages such as ease of handling and storage, lower cost, and better patient compliance.
Product Definition:
carboplatin: a chemotherapy drug used to treat ovarian.
Carboplatin Crystal:
Carboplatin is a platinum-based chemotherapy drug. It was first synthesized in the early 1960s and was approved by the U.S. FDA for use as an anti-plastic tumor agent in 1971, after which it has been used extensively as a cytotoxic drug with varied applications such as cancer treatment, lymphoma treatment & therapy, and others (such as rheumatoid arthritis).
Carboplatin Powder:
Carboplatin is a chemotherapy drug and it's used in the treatment of cancer. It belongs to the class of drugs known as alkylating agents. Carboplatin is an injectable, white crystalline powder that has excellent solubility in water and is very soluble in alcohol.
Application Insights:
Carboplatin injection was the dominant application segment in 2017 and accounted for a revenue share of 92.1%. This is due to its high preference as a single agent for the treatment of malignant brain tumors. However, it has been observed that combination therapy with other drugs can be more effective than monotherapy in treating various cancers such as lung, breast and others.
The rising prevalence of cancer across the globe is expected to boost demand for carboplatin over the forecast period. According to WHO, an estimated 9 million new cases of cancer were reported globally in 2018 which resulted in death of around 6.5 million people annually; 2/3rds died from diseases related to old age & 1/3rd from non-communicable diseases (NCDs).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, presence of key manufacturers and high healthcare expenditure in this region as compared to other regions. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising number of product approvals by regulatory agencies and growing awareness about newer generation drugs among patients.
The Latin American regional market was valued at USD X million in 2017 owing with presence of large patient pool suffering from cancer coupled with high unmet clinical needs for oncology diseases such as carboplatin-resistant ovarian cancer (CR Ovarian), bladder neck obstruction due to papillary muscle tumor (MPT) & malignant mesothelioma (MM).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global carboplatin market. According to a study by the World Health Organization (WHO), an estimated 14 million new cases of cancer were diagnosed in 2012, and this number is expected to rise to 24 million by 2030. This will create a large demand for carboplatin and other anticancer drugs, thereby driving the growth of the global carboplatin market.
- Rising awareness about cancer: There is a growing awareness among people about different types of cancers and their symptoms. This has led to an increase in early diagnosis and treatment of various forms of cancers, including ovarian cancer which can be treated with carboplatin chemotherapy drug therapy. This will further drive the growth of the global carboplatin market in coming years.
- Technological advancements in chemotherapy: The technological advancements in chemotherapy are helping improve patient outcomes with reduced side effects associated with anticancer drugs such as carboplatin therapy regimens .This is encouraging more patients to undergo chemotherapy treatment, thereby propellingthegrowthoftheglobalcarboplatinummarketinthefuture.. 4 Emerging markets: A large numberof emerging markets such as Indiaand China have a high incidence rateofcancer due tobad lifestyle habitsand environmental factors .This offers significantopportunitiesfortheglobalcarbopolatinemarkettogrowin these regions overthe forecast period 5 New drug approvals: In recent years, there have been several
Scope Of The Report
Report Attributes
Report Details
Report Title
Carboplatin Market Research Report
By Type
Carboplatin Crystal, Carboplatin Powder
By Application
Carboplatin Injection, Others
By Companies
Teva, Fresenius Kabi, Mylan, Qilu, Taj Pharmaceuticals, Tecoland Corporation, Johnson Matthey, Heraeus Deutschland
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Carboplatin Market Report Segments:
The global Carboplatin market is segmented on the basis of:
Types
Carboplatin Crystal, Carboplatin Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Carboplatin Injection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Fresenius Kabi
- Mylan
- Qilu
- Taj Pharmaceuticals
- Tecoland Corporation
- Johnson Matthey
- Heraeus Deutschland
Highlights of The Carboplatin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Carboplatin Crystal
- Carboplatin Powder
- By Application:
- Carboplatin Injection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carboplatin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Carboplatin is a chemotherapy drug used to treat various types of cancer. It works by stopping the growth of cancer cells.
Some of the key players operating in the carboplatin market are Teva, Fresenius Kabi, Mylan, Qilu, Taj Pharmaceuticals, Tecoland Corporation, Johnson Matthey, Heraeus Deutschland.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Carboplatin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Carboplatin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Carboplatin Market - Supply Chain
4.5. Global Carboplatin Market Forecast
4.5.1. Carboplatin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Carboplatin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Carboplatin Market Absolute $ Opportunity
5. Global Carboplatin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Carboplatin Market Size and Volume Forecast by Type
5.3.1. Carboplatin Crystal
5.3.2. Carboplatin Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Carboplatin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Carboplatin Market Size and Volume Forecast by Application
6.3.1. Carboplatin Injection
6.3.2. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Carboplatin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Carboplatin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Carboplatin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Carboplatin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Carboplatin Demand Share Forecast, 2019-2026
9. North America Carboplatin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Carboplatin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Carboplatin Market Size and Volume Forecast by Application
9.4.1. Carboplatin Injection
9.4.2. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Carboplatin Market Size and Volume Forecast by Type
9.7.1. Carboplatin Crystal
9.7.2. Carboplatin Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Carboplatin Demand Share Forecast, 2019-2026
10. Latin America Carboplatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Carboplatin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Carboplatin Market Size and Volume Forecast by Application
10.4.1. Carboplatin Injection
10.4.2. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Carboplatin Market Size and Volume Forecast by Type
10.7.1. Carboplatin Crystal
10.7.2. Carboplatin Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Carboplatin Demand Share Forecast, 2019-2026
11. Europe Carboplatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Carboplatin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Carboplatin Market Size and Volume Forecast by Application
11.4.1. Carboplatin Injection
11.4.2. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Carboplatin Market Size and Volume Forecast by Type
11.7.1. Carboplatin Crystal
11.7.2. Carboplatin Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Carboplatin Demand Share, 2019-2026
12. Asia Pacific Carboplatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Carboplatin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Carboplatin Market Size and Volume Forecast by Application
12.4.1. Carboplatin Injection
12.4.2. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Carboplatin Market Size and Volume Forecast by Type
12.7.1. Carboplatin Crystal
12.7.2. Carboplatin Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Carboplatin Demand Share, 2019-2026
13. Middle East & Africa Carboplatin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Carboplatin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Carboplatin Market Size and Volume Forecast by Application
13.4.1. Carboplatin Injection
13.4.2. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Carboplatin Market Size and Volume Forecast by Type
13.7.1. Carboplatin Crystal
13.7.2. Carboplatin Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Carboplatin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Carboplatin Market: Market Share Analysis
14.2. Carboplatin Distributors and Customers
14.3. Carboplatin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fresenius Kabi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mylan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qilu
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Taj Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tecoland Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Johnson Matthey
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Heraeus Deutschland
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
